SITIME Corp
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Unaudited Condensed Consolidated Financial Statements
Note 1. The Company and Basis of Presentation
SiTime Corporation (the “Company” or "SiTime") was incorporated in the State of Delaware in December 2003. The Company is a leading provider of Precision timing ("Precision Timing") solutions to the global electronics industry, providing the timing functionality that is needed for electronics to operate reliably and accurately. The Company's products have been designed to address a wide range of applications across a broad array of end markets. The Company operates a fabless business model and leverages its global network of distributors to address the broad set of end markets that it serves.
The accompanying interim condensed consolidated financial statements have been prepared in conformity with United States ("U.S.") generally accepted accounting principles ("GAAP") for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X, and should be read in conjunction with the Company's audited consolidated financial statements and related notes thereto filed with the U.S. Securities and Exchange Commission ("SEC") on Form 10-K for the fiscal year ended December 31, 2025. The interim financial statements are unaudited, but reflect all adjustments which are, in the opinion of management, of a normal, recurring nature necessary to provide a fair statement of results for the interim periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2026, for any future year, or for any other future interim period.
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The significant areas requiring the use of management estimates and assumptions include revenue recognition, fair value of earnout liabilities, estimate of write-downs for excess and obsolete inventories, and sales reserves. Actual results could differ from those estimates.
Principles of Consolidation
The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
Significant Accounting Policies
The Company’s significant accounting policies are disclosed in the Company’s audited consolidated financial statements and related notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2025. There have been no changes to these accounting policies through March 31, 2026.
Recent Accounting Pronouncements
Recently issued accounting pronouncements not yet adopted
In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses (Subtopic 220-40). The ASU requires the disaggregated disclosure of specific expense categories, including purchases of inventory, employee compensation, depreciation, and amortization, within relevant income statement captions. This ASU also requires disclosure of the total amount of selling expenses along with the definition of selling expenses. The ASU is effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Adoption of this ASU can either be applied prospectively to consolidated financial statements issued for reporting periods after the effective date of this ASU or retrospectively to any or all prior periods presented in the consolidated financial statements. Early adoption is also permitted. This ASU will likely result in the required additional disclosures being included in our consolidated financial statements, once adopted. We are currently evaluating the provisions of this ASU.
Note 2. Acquisitions
Proposed acquisition of certain assets ("Timing business") from Renesas Electronics America Inc. ("Renesas")
On February 4, 2026, we entered into an asset purchase agreement (the “Asset Purchase Agreement”) with Renesas, pursuant to which Renesas will and will cause certain of its affiliates to sell, transfer, assign and convey to SiTime all of their right, title and interest in, to and under certain assets related to the timing business of Renesas Electronics Corporation for an aggregate purchase price of approximately $1,500.0 million in cash (“Cash Consideration”) and 4.13 million shares of our common stock (such consideration, the “Stock Consideration”), subject to certain adjustments as set forth in the Asset Purchase Agreement (the “Acquisition”). As described in greater detail in the Asset Purchase Agreement, the Stock Consideration will be determined based on the volume-weighted average price of our common stock for the period of 10 consecutive trading days ending on the third full trading day prior to the consummation of the Acquisition (the “Closing”), subject to a floor price of $308.6686 and a ceiling price of $417.6104, which could result in approximately 3.59 million shares to 4.86 million shares being issued. Mr. Hidetoshi Shibata, CEO of Renesas, will join SiTime’s Board of Directors after the close of the transaction.
The Closing is subject to the satisfaction of certain customary conditions, including the accuracy of each party’s representations and warranties as of the Closing, subject in certain instances, to certain materiality and other thresholds, the performance by each party of its obligations and covenants under the Asset Purchase Agreement in all material respects, the expiration or termination of the applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the receipt of other governmental approvals in certain foreign jurisdictions.
Also on February 4, 2026, in connection with our entry into the Asset Purchase Agreement, we entered into a debt financing commitment letter (the “Commitment Letter”) with Wells Fargo Securities, LLC and Wells Fargo Bank, National Association (collectively, “Wells Fargo”), pursuant to which Wells Fargo has committed to provide us with debt financing to fund a portion of the Cash Consideration in an aggregate principal amount of up to $900.0 million in the form of a 364-day senior secured bridge loan facility (the “Bridge Facility”), subject to customary conditions. Subject to market conditions and other factors, in lieu of all or a portion of the Bridge Facility, we may fund a portion of the Acquisition consideration through one or more bank financing or capital markets transactions. The consummation of the Acquisition is not conditioned on the availability of the Bridge Facility or any alternative financing. The unamortized portion of the debt issuance costs related to the Bridge Facility and future financing transactions amounting to $2.0 million is included in "Other assets" in the condensed consolidated balance sheets as of March 31, 2026.
Note 3. Fair Value Measurements
Cash equivalents
At March 31, 2026 and December 31, 2025, highly liquid money market funds of $484.6 million and $0.4 million, respectively, were valued using Level 1 of the fair value hierarchy, quoted prices in active markets for identical assets, and are included in cash equivalents.
Short-term investments in held-to-maturity securities
As of March 31, 2026 and December 31, 2025, the Company had purchased Treasury Bills with maturities ranging from 3 to 6 months, which the Company intends to hold until maturity and has classified as held-to-maturity securities. The held-to-maturity securities are recorded at amortized cost totaling $290.2 million including gross accrued interest of $3.6 million as of March 31, 2026. As of March 31, 2026, the fair value on the held-to-maturity securities was $290.2 million and the gross unrealized loss was immaterial.
As of December 31, 2025, the amortized cost of the held-to-maturity securities totaled $791.6 million including gross accrued interest of $7.8 million. As of December 31, 2025, the fair value and gross unrealized gain on the held-to-maturity securities was $792.1 million and $0.5 million, respectively.
These treasury bills were valued using Level 1 of the fair value hierarchy, quoted prices in active markets for identical assets, and are included in short-term investments. The carrying value of our investments is reviewed quarterly for changes in circumstances or the occurrence of events that suggests an investment may not be fully recoverable.
Sales-based earnout liability
Sales-based earnout is paid based on various multiples of future revenue to be generated through December 31, 2028 from acquired intellectual property. The estimated fair value of the sales-based earnout liability is determined using a Monte Carlo simulation model using significant unobservable fair value inputs and is therefore classified as a Level 3 measurement. The assumptions used in the calculation are based on the revenue projections over the term of the contingent earn-out period, expected volatility, and discount rate. The estimates of fair value are uncertain and changes in any of the estimated inputs used will result in significant adjustments to the fair value. As of March 31, 2026, the Company used a volatility rate of 22%, risk free rate ranging from 3.7% to 3.8%, and an expected term ranging from 0.13 years to 2.63 years.
The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities:
| Amount | |
|---|---|
| Fair value as of January 1, 2026 | $88,353 |
| Change in the fair value during the year recorded to acquisition related costs | (1,364) |
| Payments made during the period | (3,966) |
| Fair value as of March 31, 2026 | $83,023 |
There were no transfers between Level 1, Level 2, and Level 3 categories during any of the periods presented.
Note 4. Balance Sheet Components
Accounts Receivable, net
Accounts receivable, net consisted of the following:
| As of | ||
|---|---|---|
| March 31, 2026 | December 31, 2025 | |
| (in thousands) | ||
| Accounts receivable, gross | $55,047 | $45,090 |
| Allowance for credit losses | (50) | (50) |
| Accounts receivable, net | $54,997 | $45,040 |
Inventories
Inventories consisted of the following:
| As of | ||
|---|---|---|
| March 31, 2026 | December 31, 2025 | |
| (in thousands) | ||
| Raw materials | $12,622 | $13,572 |
| Work in progress | 60,307 | 47,485 |
| Finished goods | 18,193 | 20,500 |
| Total inventories | $91,122 | $81,557 |
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following:
| As of | ||
|---|---|---|
| March 31, 2026 | December 31, 2025 | |
| (in thousands) | ||
| Prepaid expenses | $7,164 | $6,761 |
| Other current assets | 7,269 | 7,514 |
| Total prepaid expenses and other current assets | $14,433 | $14,275 |
Property and Equipment, net
Property and equipment, net consisted of the following:
| As of | ||
|---|---|---|
| March 31, 2026 | December 31, 2025 | |
| (in thousands) | ||
| Lab and manufacturing equipment | $166,507 | $158,909 |
| Computer equipment | 4,032 | 3,928 |
| Furniture and fixtures | 1,196 | 1,152 |
| Construction in progress | 16,095 | 15,885 |
| Leasehold improvements | 8,234 | 8,303 |
| 196,064 | 188,177 | |
| Accumulated depreciation | (89,403) | (83,063) |
| Total property and equipment, net | $106,661 | $105,114 |
Depreciation expense related to property and equipment was $6.4 million and $5.1 million for the three months ended March 31, 2026 and 2025, respectively.
Intangible Assets, net
Intangible assets, net consisted of the following:
| As of | ||||||
|---|---|---|---|---|---|---|
| March 31, 2026 · December 31, 2025 | ||||||
| (in thousands) | ||||||
| Gross Assets | Accumulated Amortization | Net Assets | Gross Assets | Accumulated Amortization | Net Assets | |
| Developed technology | $166,200 | $(29,910) | $136,290 | $166,200 | $(24,534) | $141,666 |
| Contract based royalty asset | 5,900 | (3,442) | 2,458 | 5,900 | (3,073) | 2,827 |
| Purchased software | 3,657 | (833) | 2,824 | 3,454 | (581) | 2,873 |
| Total intangible assets | $175,757 | $(34,185) | $141,572 | $175,554 | $(28,188) | $147,366 |
Amortization expense for intangible assets was $6.0 million and $3.9 million for the three months ended March 31, 2026 and 2025, respectively.
The estimated aggregate future amortization expense for intangible assets subject to amortization as of March 31, 2026 is summarized as below:
| (in thousands) | |
|---|---|
| 2026 (remainder) | $17,909 |
| 2027 | 23,545 |
| 2028 | 21,778 |
| 2029 | 19,874 |
| 2030 | 19,815 |
| 2031 and beyond | 38,651 |
| $141,572 | |
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following:
| As of | ||
|---|---|---|
| March 31, 2026 | December 31, 2025 | |
| (in thousands) | ||
| Accrued payroll and related benefits | $9,267 | $14,007 |
| Revenue reserves | 3,024 | 3,655 |
| Sales-based earnout liability, current | 25,821 | 35,007 |
| Short term lease liability | 2,419 | 2,478 |
| Other accrued expenses | 12,637 | 7,531 |
| Total accrued expenses and other current liabilities | $53,168 | $62,678 |
Other Non-current Liabilities
Other non-current liabilities consisted of the following:
| As of | ||
|---|---|---|
| March 31, 2026 | December 31, 2025 | |
| (in thousands) | ||
| Sales-based earnout liability, non-current | $57,202 | $53,346 |
| Long term lease liability | 537 | 1,132 |
| Other non-current liabilities | 58 | 34 |
| Total other non-current liabilities | $57,797 | $54,512 |
Note 5. Leases
The Company leases office space in California, Michigan, Malaysia, Japan, Taiwan, the Netherlands, Finland, Ukraine, and India, all under non-cancellable operating leases with various expiration dates through May 2029.
The remaining lease terms vary from a few months tofour years. For certain of its leases the Company has options to extend the lease term for periods varying fromone tofive years. These renewal options are not considered in the remaining lease term unless it is reasonably certain that the Company will exercise such options. The Company also has variable lease payments that are primarily comprised of common area maintenance and utility charges.
The Company has entered into an operating lease arrangement that has not yet commenced as of March 31, 2026. This lease primarily relates to office facilities in California. As the commencement date has not occurred, the related right‑of‑use assets and lease liabilities have not been recognized in the condensed consolidated balance sheets as of March 31, 2026. The undiscounted future minimum lease payments under this lease are approximately $83.2 million.
The table below presents the operating lease-related assets and liabilities recorded on the condensed consolidated balance sheets as of March 31, 2026 and December 31, 2025:
| As of | ||
|---|---|---|
| March 31, 2026 | December 31, 2025 | |
| (in thousands) | ||
| Right-of-use assets | $3,479 | $4,089 |
| Lease liabilities included in accrued expenses and other current liabilities | 2,419 | 2,478 |
| Lease liabilities included in other non-current liabilities | 537 | 1,132 |
| Total operating lease liabilities | $2,956 | $3,610 |
| Weighted-average remaining lease term (years) | 1.5 | 1.6 |
| Weighted-average discount rate | 5.4% | 5.3% |
The table below presents certain information related to the lease costs for operating leases for the three months ended March 31, 2026 and 2025:
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2026 | 2025 | |
| (in thousands) | ||
| Operating lease cost | $741 | $805 |
| Short-term lease cost | 345 | 505 |
| Variable lease cost | 808 | 1,024 |
| Total lease cost | $1,894 | $2,334 |
Cash paid for operating lease liabilities was $0.8 million and $0.8 million for the three months ended March 31, 2026 and 2025, respectively.
Operating Lease Cash Flows
The table below reconciles the undiscounted cash flows for each of the first five years and total of the remaining years to the operating lease liabilities recorded on the condensed consolidated balance sheet as of March 31, 2026:
| (in thousands) | |
|---|---|
| Remainder of 2026 | $2,032 |
| 2027 | 756 |
| 2028 | 221 |
| 2029 | 82 |
| Total minimum lease payments | 3,091 |
| Less: amount of lease payments representing interest | (135) |
| Present value of future minimum lease payments | 2,956 |
| Less: current obligations under leases | (2,419) |
| Long-term lease liabilities | $537 |
Note 6. Stockholders’ Equity
At-The-Market offering
On February 27, 2024, the Company entered into a Sales Agreement ("Sales Agreement"), with Stifel, Nicolaus & Company, Incorporated ("Stifel"), under which the Company may offer and sell from time to time at its sole discretion, up to an aggregate of 1,200,000 shares of its common stock, par value $0.0001 per share, through Stifel acting as its sales agent.
During the three months ended March 31, 2026 and March 31, 2025, the Company did not sell any shares of its common stock through Stifel under the Sales Agreement.
Equity Incentive Plans
The following table summarizes the RSU, performance based restricted stock units ("PRSU"), and multi-year performance restricted stock units ("MYPSU") activity for the three months ended March 31, 2026:
| RSUNumberofShares | Grant DateFairValueper share | PRSUNumberofShares | Grant DateFairValueper share | MYPSUNumberofShares | Grant DateFairValueper share | |
|---|---|---|---|---|---|---|
| Unvested at December 31, 2025 | 682,991 | $150.7 | 312,519 | $135.1 | 285,880 | $88.6 |
| Granted | 201,282 | 409.9 | 149,725 | 310.5 | — | — |
| Vested | (113,680) | 179.6 | (53,090) | 167.8 | — | — |
| Forfeited | (10,333) | 189.6 | — | — | — | — |
| Unvested at March 31, 2026 | 760,260 | $214.4 | 409,154 | $195.0 | 285,880 | $88.6 |
The following summarizes the number and value of the shares withheld for employee taxes:
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2026 | 2025 | |
| (in thousands, except share data) | ||
| Shares withheld for taxes | 68,938 | 74,833 |
| Amount withheld for taxes | $27,831 | $13,479 |
In February 2026, the Compensation Committee of the Company approved PRSUs for the fiscal year 2026 with performance goals based on the achievement of relative total stockholder return with athree year performance period (the "2026 TSR PRSU Goals"). The grant-date fair value of each PRSU was determined using Monte Carlo simulation model. The assumptions used in the Monte Carlo simulation for the awards included expected volatility of 70.5%, risk free rate of 3.5%, no expected dividend yield and expected term of 2.9 years. The Company recognizes the expense related to the 2026 TSR PRSU Goals on a graded-vesting method over the requisite performance period. These grants are included in the PRSU awards granted in the table above.
Stock-Based Compensation
The following table presents the detail of stock-based compensation expense amounts included in the condensed consolidated statement of operations for each of the periods presented:
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2026 | 2025 | |
| (in thousands) | ||
| Equity based awards | ||
| Cost of revenue | $526 | $632 |
| Research and development | 10,301 | 10,032 |
| Selling, general and administrative | 17,847 | 13,016 |
| $28,674 | $23,680 | |
| Liability based awards - to be settled in equity | ||
| Cost of revenue | $64 | $68 |
| Research and development | 927 | 650 |
| Selling, general and administrative | 1,135 | 648 |
| $2,126 | $1,366 | |
| Total stock-based compensation expense - equity and liability based | $30,800 | $25,046 |
| Stock-based compensation expense recorded to additional paid-in capital | ||
| Equity based awards | $28,674 | $23,680 |
| Liability based awards - settled in equity | 7,170 | 6,475 |
| Stock-based compensation expense capitalized to inventory | — | (4) |
| Total stock-based compensation expense recorded to additional paid-in capital | $35,844 | $30,151 |
The following table presents the unrecognized compensation costs and related weighted average period of recognition as of March 31, 2026:
| Unrecognized Compensation Costs (in millions) | Weighted Average Period of Recognition (in years) | |
|---|---|---|
| RSUs | $135.8 | 2.1 |
| PRSUs | $55.5 | 1.5 |
| Liability-based awards | $10.6 | 0.7 |
Note 7. Income Taxes
The quarterly provision for income taxes is based on applying the estimated annual effective tax rate to the year to date pre-tax income, plus any discrete items. The Company updates its estimate of its annual effective tax rate at the end of each quarterly period. The estimate takes into account annual forecasted income before income taxes, the geographic mix of income before income taxes and any significant permanent tax items.
The following table presents the provision for income taxes and the effective tax rates for the three months ended March 31, 2026 and 2025:
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2026 | 2025 | |
| (in thousands) | ||
| Loss before income taxes | $(5,203) | $(23,810) |
| Income tax expense | (14) | (67) |
| Effective tax rate | 0.3% | 0.3% |
The Company’s effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in tax jurisdictions with different statutory rates, benefits related to tax credits and the tax impact of non-deductible expenses, existence of full valuation allowance on its deferred tax assets, and other permanent differences between income before income taxes and taxable income.
A valuation allowance is established or maintained when, based on currently available information and other factors, it is more likely than not that all or a portion of the deferred tax assets will not be realized. The Company regularly assesses its valuation allowance against deferred tax assets on a jurisdiction by jurisdiction basis. The Company considers all available positive and negative evidence, including future reversals of temporary differences, projected future taxable income, tax planning strategies and recent financial results. Based on management’s assessment of the realizability of deferred tax assets, the Company continues to maintain a full valuation allowance on its deferred tax assets as of March 31, 2026.
The income tax provision was immaterial for both the three months ended March 31, 2026 and 2025. The provision for income taxes is primarily related to the foreign subsidiaries’ local country obligations. The U.S. effective tax rate is less than 1% and is due to minimum state tax. There is no federal provision for income taxes as the Company has sufficient carryforward of net operating losses to offset any operating income earned since inception and has projected an operating loss in the current year.
As of March 31, 2026 and December 31, 2025, the Company had $2.5 million of total unrecognized tax benefits. If the Company is able to eventually recognize these uncertain tax positions, none of the unrecognized benefits would reduce the Company’s effective tax rate due to the full valuation allowance on the Company’s deferred tax assets.
The Company’s policy is to record interest and penalties related to unrecognized tax benefits as income tax expense. For the three months ended March 31, 2026 and 2025, the Company recorded immaterial amounts related to the accrual of interest and penalties.
Note 8. Segment, Geographic and Customer Information
The Company operates inone reportable segment related to the design, development, and sale of Precision Timing solutions to the global electronics industry.
The accounting policies of the Company’s single segment and key performance measures used by the Chief Executive Officer, who is the Chief Operating Decision Maker, to assess the performance of the Company are the same as those described within Note 1 and Note 11 of the Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on February 11, 2026.
The table below provides information about the Company’s revenue, significant segment expenses and other segment expenses.
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2026 | 2025 | |
| (in thousands) | ||
| Revenue | $113,567 | $60,314 |
| Less: | ||
| Product costs | 30,316 | 18,264 |
| Depreciation | 4,343 | 3,200 |
| Amortization | 5,751 | 3,579 |
| Other manufacturing overheads | 6,202 | 4,935 |
| Gross profit | 66,955 | 30,336 |
| Less: | ||
| Acquisition related costs | 7,619 | 1,562 |
| Interest income | (7,310) | (4,294) |
| Other segment items (a) | 71,863 | 56,945 |
| Net loss | $(5,217) | $(23,877) |
(a)Other segment items include research and development expenses and selling, general and administrative expenses, primarily in the nature of nonmanufacturing expenses including salaries and stock-based compensation for employees, consulting expenses, depreciation and amortization expenses, certain other expenses, and taxes.
Note 9. Commitments and Contingencies
Legal Matters
From time to time, the Company may be a party to various litigation claims in the normal course of business. Legal fees and other costs associated with such actions are expensed as incurred. The Company assesses, in conjunction with legal counsel, the need to record a liability for litigation and contingencies. Accrual estimates are recorded when and if it is determined that such a liability for litigation and contingencies are both probable and reasonably estimable. We did not have any amounts accrued towards these matters as of March 31, 2026.
Indemnification
The Company is a party to a variety of agreements pursuant to which it may be obligated to indemnify other parties to such agreements with respect to certain matters. Typically, these obligations arise in the context of contracts that the Company has entered into, under which the Company customarily agrees to hold the other party harmless against losses arising from a breach of representations and covenants or terms and conditions related to such matters as the sale and/or delivery of its products, title to assets sold, certain intellectual property claims, defective products, and specified environmental matters. Further, the Company’s obligations under these agreements may be limited in terms of time, amount, or the scope of its responsibility and in some instances, the Company may have recourse against third-parties for certain payments made under these agreements. It is not possible to predict the maximum potential amount of future payments under these agreements due to the conditional nature of the Company’s obligations and the unique facts and circumstances involved in each particular agreement. Historically, the Company has had no material indemnification claims under these agreements.
Purchase Commitments
The Company purchases components from a variety of suppliers and uses several contract manufacturers to provide manufacturing services for its products. During the normal course of business, in order to manage manufacturing lead times and to help ensure adequate component supply, the Company enters into agreements with the Company’s contract manufacturers and suppliers that allow them to procure inventory based upon criteria as defined by the Company. In addition, the Company has a multi-year agreement to purchase minimum quantities of micro-electro-mechanical systems ("MEMS") wafers and is responsible for research and development, tooling, and samples cost under the agreement. A portion of the Company’s reported purchase commitments arising from these agreements consists of firm, non-cancelable purchase commitments. In certain instances, these agreements allow the Company the option to cancel, reschedule, and adjust the Company’s requirements based on its business needs prior to when production starts. However, in situations where the Company is unable to cancel, reschedule, or adjust the purchase commitment due to changing customer demand, excess inventories could result in material inventory provisions. Total future non-cancelable purchase commitments as of March 31, 2026 were as follows:
| (in thousands) | |
|---|---|
| Remainder of 2026 | $13,136 |
| 2027 | 9,448 |
| 2028 | 8,098 |
| Total | $30,682 |
Note 10. Net Loss Per Share
The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company:
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| (in thousands, except per share data) | ||
| Net loss attributable to common stockholders | $(5,217) | $(23,877) |
| Weighted average shares used to compute basic and diluted net loss per share | 26,343 | 23,653 |
| Net loss attributable to common stockholders per share, basic and diluted | $(0.20) | $(1.01) |
Potential dilutive securities include dilutive common shares from share-based awards attributable to the restricted stock unit awards calculated using the treasury stock method. Under the treasury stock method, potential common shares outstanding are not included in the computation of diluted net income per share if their effect is anti-dilutive.
Anti-dilutive potential shares from share-based awards are excluded from the calculation of diluted earnings per share if either their exercise price exceeded the average market price during the period, or the share-based awards were determined to be anti-dilutive based on applying the treasury stock method. During the three months ended March 31, 2026 and 2025, the Company had 515,319 and 468,358 potential shares from restricted stock units that are anti-dilutive, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.